[1]李盈,周伟生.胶质细胞瘤诊断及介入治疗研究进展[J].介入放射学杂志,2007,(04):284.
　LI Ying,ZHOU Wei-sheng.Evolvements on diagnosis and interventional therapy of glioblastoma[J].journal interventional radiology,2007,(04):284.
点击复制

胶质细胞瘤诊断及介入治疗研究进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年04期
页码:
284
栏目:
综述
出版日期:
2007-04-15

文章信息/Info

Title:
Evolvements on diagnosis and interventional therapy of glioblastoma
作者:
李盈; 周伟生
５１０４０５广州中医药大学第一附属医院介入中心
Author(s):
LI Ying; ZHOU Wei-sheng
The First Affiliated Hospital，Guangzhou University of TCM，Guangzhou５１０４０５，China
关键词:
胶质细胞瘤; 磁共振成像; 血管生成; 超选择血管内灌注
分类号:
R７３０.２６４
文献标志码:
A
摘要:
MRI与超声技术在胶质细胞瘤的诊断中不断改进，增强了临床诊断价值。超选择血管内灌注化疗／放疗具有创伤小、局部疗效明显、不良反应较轻等优势，治疗上较重视抑制血管生成，以药物化疗为主，具有广阔应用前景。有待加强对药物作用机制、肿瘤复发机制方面的研究。降低诊断成本，提高新技术的准确性、可靠性，加强超选择血管内灌注与化疗药物配合使用的研究，在今后研究中具有重要意义。

参考文献/References:

［１］Vonken EP，van Osch MJ，Willems PW，et al．Repeated quantitative perfusion and contrast permeability measurement in the MRI examination of a CNS tumor［J］．Eur Radiol，２０００，１０：１４４７-１４５１．
［２］Nasel C，Schindler E．Xenon-CT and perfusion MRI in the diagnosis of cerebral gliomas［J］．Radiologe，１９９８，３８：９３０-９３４．
［３］Chang YW，Yoon HK，Shin HJ，et al．MR imaging of glioblastoma in children：usefulness of diffusion／perfusion-weighted MRI and MR spectroscopy［J］．Pediatr Radiol，２００３，３３：８３６-８４２．
［４］Principi M，Italiani M，Guiducci A，et al．Perfusion MRI in the evaluation of the relationship between tumour growth，necrosis and angiogenesis in glioblastomas and grade１meningiomas［J］．Neuroradiology，２００３，４５：２０５-２１１．
［５］Sugahara T，Korogi Y，Kochi M，et al．Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas［J］．Am J Roentgenol，１９９８，１７１：１４７９-１４８６．
［６］Knopp EA，Cha S，Johnson G，et al．Glial neoplasms：dynamic contrast-enhanced T２觹-weighted MR imaging［J］．Radiology，１９９９，２１１：７９１-７９８．
［７］Preul C，Kuhn B，Lang EW，et al．Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging［J］．Eur J Radiol，２００３，４８：２４４-２５１．
［８］Lee SJ，Kim JH，Kim YM，et al．Perfusion MR imaging in gliomas：comparison with histologic tumorgrade［J］．Korean J Radiol，２００１，２：１-７．
［９］Maia AC，Malheiros SM，da Rocha AJ，et al．Stereotactic biop-sy guidance in adults with supratentorial nonenhancing gliomas：role of perfusion-weighted magnetic resonance imaging［J］．J Neurosury，２００４，１０１：９７０-９７６．
［１０］Muti M，Aprile I，Principi M，et al．Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas［J］．Radiol Med，２００２，１０４：８７-９１．
［１１］Aprile I，Muti M，Principi M，et al．A Magnetic Resonance comparative study betweenenhancement，rCBV and ACD in brain glioblastomas［J］．Radiol Med，２００２，１０４：８７-９１．
［１２］Matheus MG，Castillo M，Ewend M，et al．CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor：initial experience［J］．Am J Neuroradiol，２００４，２５：１２１１-１２１７．
［１３］Oh J，Henry RG，Pirzkall A，et al．Survival analysis in patientswith glioblastoma multiforme：predictive value of choline-to-N-acetylaspartate index，apparent diffusion coefficient，and relative cerebral blood volume［J］．J Magn Reson Imaging，２００４，１９：５４６-５５４．
［１４］Grosu AL，Weber WA，Franz M，et al．Reirradiation of recur-rent high-grade gliomas using amino acid PET（SPECT）／CT／MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy，Int J Radiat Oncol Biol Phys，２００５，Oct１：６３：５１１-５１９．
［１５］Jackson A，Jayson GG，Li KL，et al．Reproducibility of quanti-tative dynamic contrast-enhanced MRI in newly presenting glioma［J］．Br J Radiol，２００３，７６：１５３-１６２．
［１６］Ellegala DB，Leong-Poi H，Carpenter JE，et al．Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha（v）beta３［J］．Circulation，２００３，１０８：３３６-３４１．
［１７］Qureshi AI，Suri MF，Khan J，et al．Superselective intra-arterial carboplatin for treatment of intracranial neoplasms：experience in１００procedure［J］．J Neurooncol，２００１，５１：１５１-１５８．
［１８］Watanabe W，Kuwabara R，Nakahara T，et al．Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas［J］．Graefe's Arch Clin Exp Ophthalmol，２００２，２４０：１０３３-１０３５．
［１９］Silvani A，Eoli M，Salmaggi A，et al．Intra-arterial ACNU and car-boplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patient with glioblastoma［J］．Neurol Sci，２００２，２３：２１９-２２４．
［２０］Kragh M，Quistorff B，Tenan M，et al．Overexpression of throm-bospondin-１reduces growth and vascular index but not perfusion in glioblastoma［J］．Cancer Res，２００２，１５，６２：１１９１-１１９５．
［２１］Filleur S，Volpert OV，Degeorges A，et al．In vivo mechanisms by which tumors producing thrombospondin１bypass its inhibitory effect［J］．Genes Dev，２００１，１５：１３７３-１３８２．
［２２］Abdollahi A，Lipson KE，Sckell A，et al．Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects［J］．Cancer Res，２００３，６３：８８９０-８８９８．
［２３］Vajkoczy P，Menger MD，Vollmar B，et al．Inhibition of tumor growth，angiogenesis，and microcirculation by the novel F１k-１inhibitor SU５４１６as assessed by intravital multi-fluorescence videomicroscopy［J］．Neplasia，１９９９，１：３１-４１．
［２４］Schuuring J，Bussink J，Bernsen HJ，et al．Irradiation com-bined with SU５４１６：microvascular changes and growth delay in a human xenograft glioblastoma tumor line［J］．Int J Radiat Oncol Biol Phys，２００５，６１：５２９-５３４．
［２５］Tsai NM，Lin SZ，Lee CC，et al．The antitumor effects of Ange-lica sinensis on malignant brain tumors in vitro and in vivo［J］．Clin Cancer Res，２００５，１１：３４７５-３４８４．
［２６］Rustamzadeh E，Hall WA，Todhunter DA，et al．Intracranial therapy of glioblastoma with the fusion protein DTIL１３in immunodeficient mice［J］．Int J Cancer，２００６，１１８：２５９４-２６０１．

相似文献/References:

[1]袁正,叶晓丹,董生,等.３１ P－MR波谱分析技术评价化疗栓塞治疗肝细胞癌疗效的初步研究[J].介入放射学杂志,2008,(11):779.
　YUAN Zheng,YE Xiaodan,DONG Sheng,et al.Value of ３１ P MR spectroscopy in monitoring the early response of hepatocellular carcinoma to transcatheter arterial chemoembolization[J].journal interventional radiology,2008,(04):779.
[2]姜永能,胡继红,邬明,等.肝脏局灶性结节增生的DSA和MRI 诊断[J].介入放射学杂志,2010,(07):531.
　JIANG Yongneng,HU Jihong,WU Ming,et al.DSA and MRI diagnosis of hepatic focal nodular hyperplasia[J].journal interventional radiology,2010,(04):531.
[3]王维英,邓钢,李爱梅,等.诱导后大鼠胰岛素分泌细胞超顺磁化氧化铁颗粒 - 多聚左旋赖氨酸体外标记后生物活性研究[J].介入放射学杂志,2007,(02):104.
　WANG Wei-ying,DENG Gang,LI Ai-mei,et al.Characterization of biophysical properties of insulin-producing cells labeled with SPIO-PLL in vitro[J].journal interventional radiology,2007,(04):104.
[4]王舒,王磊,杨庭树.磁共振冠状动脉造影的研究进展[J].介入放射学杂志,2007,(02):139.
　WANG Shu,WANG Lei,YANG Ting-shu.Research advance in coronary magnetic resonance angiography[J].journal interventional radiology,2007,(04):139.
[5]黄浙勇,葛均波,杨姗,等.铁羧葡胺标记猪间充质干细胞的体内外磁共振成像研究[J].介入放射学杂志,2007,(02):115.
　HUANG Zhe-yong,GE Jun-bo,YANG Shan,et al.In vitro and in vivo MR imaging of SHU５５５A-labelled swine bone marrow mesenchymal stem cells[J].journal interventional radiology,2007,(04):115.
[6]况圣佳,左慧英,辜斌.ERCP与MRCP对胆道恶性梗阻诊断价值的分析比较[J].介入放射学杂志,2007,(10):673.
　KUANG Sheng-jia,ZUO Hui-ying,KU Bin.A comparative study on diagnostic value of endoscopic retrograde cholangiopancreatography and MR cholangiopancreatography in malignant biliary obstraction[J].journal interventional radiology,2007,(04):673.
[7]袁正,肖湘生,刘士远,等.磁共振扩散加权成像在肝癌TACE术后随访中的定性和定量应用[J].介入放射学杂志,2007,(12):820.
　YUAN Zheng,XIAO Xiang-sheng,LIU Shi-yuan,et al.Diffusion-weighted MR imaging for liver cancer follow-up after transcatheter arterial chemoembolization[J].journal interventional radiology,2007,(04):820.
[8]夏彩凤,顾建平.功能磁共振成像在下肢骨骼肌缺血损伤中的应用[J].介入放射学杂志,2011,(10):836.
　XIA Cai-feng,GU Jian-ping.. The application of functional MRI in evaluating ischemic injuries of lower limb skeletal muscle[J].journal interventional radiology,2011,(04):836.
[9]冯敏,王书智,顾建平,等.磁共振血管成像在髂静脉受压综合征中的诊断价值[J].介入放射学杂志,2008,(01):26.
　FENG Min,WANG Shuzhi,GU Jianping,et al.The diagnostic value of MRA in detection of iliac vein compression syndrome[J].journal interventional radiology,2008,(04):26.
[10]徐凯,李麟荪.布加综合征的CT和MRI 诊断[J].介入放射学杂志,2008,(04):294.
　XU Kai,LI Lingsun.Budd－Chiari syndrome ：CT and MRI findings[J].journal interventional radiology,2008,(04):294.

备注/Memo

备注/Memo:
收稿日期：２００６-０８-２９
更新日期/Last Update: 2007-04-15